BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

Latest DEFA14A SEC Filings
Additional definitive proxy soliciting materials and Rule 14(a)(12) material

VIRAGEN INC, DEFA14A, 2001-01-09
GENZYME CORP, DEFA14A, 2000-11-29
GENZYME CORP, DEFA14A, 2000-11-07
NORTHFIELD LABORATORIES INC /DE/, DEFA14A, 2000-10-11
NORTHFIELD LABORATORIES INC /DE/, DEFA14A, 2000-09-27
NORTHFIELD LABORATORIES INC /DE/, DEFA14A, 2000-08-28
NORTHFIELD LABORATORIES INC /DE/, DEFA14A, 2000-08-25
NORTHFIELD LABORATORIES INC /DE/, DEFA14A, 2000-08-18
LIFE TECHNOLOGIES INC, DEFA14A, 2000-07-11
LIFE TECHNOLOGIES INC, DEFA14A, 2000-07-10
GLIATECH INC, DEFA14A, 2000-07-07
GENZYME CORP, DEFA14A, 2000-05-30
TRANSKARYOTIC THERAPIES INC, DEFA14A, 2000-05-23
GENZYME CORP, DEFA14A, 2000-05-11
CEL SCI CORP, DEFA14A, 2000-05-10
NORTHFIELD LABORATORIES INC /DE/, DEFA14A, 1999-09-24
RIBI IMMUNOCHEM RESEARCH INC, DEFA14A, 1999-08-19
TREGA BIOSCIENCES INC, DEFA14A, 1999-04-20
GENEMEDICINE INC, DEFA14A, 1999-02-22
PROCEPT INC, DEFA14A, 1998-05-06
PROCEPT INC, DEFA14A, 1997-07-03
GENZYME CORP, DEFA14A, 1997-06-04
MEDIMMUNE INC /DE, DEFA14A, 1997-04-30
LA JOLLA PHARMACEUTICAL CO, DEFA14A, 1997-04-08
HUMAN GENOME SCIENCES INC, DEFA14A, 1996-05-10
AMGEN INC, DEFA14A, 1995-04-26


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission